Sumatriptan Succinate
Product Images NDC 68151-1658
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 68151-1658). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical-structure (Chemical Structure)
Sumatriptan-figure-1 (Sumatriptan Figure 1)
The figure presents the estimated probability of achieving initial headache response within 4 hours of treatment with oral sumatriptan. The response is based on no or mild pain. The plot is a Kaplan-Meier plot with different doses, including 25mg, 50mg, and 100mg, along with a placebo. The data used to generate this plot is obtained from pooled data of 3 clinical controlled trials, providing evidence of efficacy. The x-axis represents time in minutes from the initial dose, and the y-axis represents the estimated probability of treatment response.*
Sumatriptan-figure-2 (Sumatriptan Figure 2)
This is a graph showing the estimated probability of patients taking a second dose of sumatriptan succinate tablets or other medication to treat migraines over the 24 hours following the initial dose of the study treatment. The data is obtained from pooled trials 1, 2, and 3. The Kaplan-Meier plot is based on data obtained in three clinical trials providing evidence of efficacy with patients not using additional treatments censored to 24 hours. Patients who had no response to the initial dose are also included. No remedication was allowed within 2 hours postdose.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.